Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01782448

Ligand	Ligand name	Chain	PDB	Tanimoto
DM7	4'-DEOXY-4'-IODODOXORUBICIN	A	1IMR	0.7
DM7	4'-DEOXY-4'-IODODOXORUBICIN	A	1IMS	0.7
32P	3-{2-[(5-AMINOPENTYL)AMINO]-2-OXOETHOXY}-5-({[1-(4-FLUOROPHENYL)ETHYL]AMINO}CARBONYL)PHENYL PHENYLMETHANESULFONATE	A	1TQF	0.72
DM1	DAUNOMYCIN	A	152D	0.71
DM1	DAUNOMYCIN	A,B,C,D	1O0K	0.71
DM1	DAUNOMYCIN	A	1JO2	0.71
DM1	DAUNOMYCIN	A,B	308D	0.71
DM1	DAUNOMYCIN	A	1D33	0.71
DM1	DAUNOMYCIN	A	110D	0.71
DM1	DAUNOMYCIN	A	1D11	0.71
DM1	DAUNOMYCIN	A	427D	0.71
DM1	DAUNOMYCIN	A	2D34	0.71
DM1	DAUNOMYCIN	A	3F8F	0.71
DM1	DAUNOMYCIN	A	1D10	0.71
DM1	DAUNOMYCIN	A	1DA0	0.71
DM3	6-DEOXYDAUNOMYCIN	A	1D14	0.71
DM6	4'-EPIDOXORUBICIN	A	1D15	0.71
DM6	4'-EPIDOXORUBICIN	A	1D54	0.71
DM6	4'-EPIDOXORUBICIN	A	1D58	0.71
DM6	4'-EPIDOXORUBICIN	A	1QDA	0.71
DM2	DOXORUBICIN	A	2DR6	0.71
DM2	DOXORUBICIN	A	1P20	0.71
DM2	DOXORUBICIN	A	1I1E	0.71
DM2	DOXORUBICIN	A	151D	0.71
DM2	DOXORUBICIN	A	1D12	0.71
DM2	DOXORUBICIN	A	1DA9	0.71
FLQ	N-[6-(ACETYLAMINO)HEXYL]-3',6'-DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-6-CARBOXAMIDE	C	2FDC	0.73
FLU	2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID	L	1FLR	0.71
FLU	2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID	A,B	1N0S	0.71
FLU	2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID	C,L	1T66	0.71
FLU	2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID	A	1X9Q	0.71
FLU	2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID	A,D	2NMV	0.71
LK1	N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-L-GLUTAMIC ACID	A	2JFH	0.79
U03	4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE	A	3UPJ	0.71
LKM	N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	A	2VTD	0.75
LK2	N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-D-GLUTAMIC ACID	A	2JFF	0.79
MBS		A,B	1HY7	0.74
886	N-({4'-[(4-isobutyrylphenoxy)methyl]biphenyl-4-yl}sulfonyl)-D-valine	A,B,C,D	2RJP	0.85
LK4	N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	A	2UUP	0.76
LK4	N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	A	2VTE	0.76
AGG	TIROFIBAN	A,B	2VDM	0.71
MAR	4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN	A	1D36	0.7
MAR	4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN	A	1R68	0.7
MAR	4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN	A	1D35	0.7
LK3	N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID	A	2UUO	0.79
REF	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione	A	2ZJW	0.71
FDS	FLUORESCIN	H	4FAB	0.75
FL1	5-{[({2-[4-(AMINOSULFONYL)PHENYL]ETHYL}AMINO)CARBONOTHIOYL]AMINO}-2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)BENZOIC ACID	A	2F14	0.71
CYF	5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)-ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A-DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID	L,P	1MPA	0.7
CYF	5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)-ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A-DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID	L,P	2MPA	0.7
CYF	5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)-ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A-DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID	I,L	1DZH	0.7